Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy
NKT cells, unique lymphocytes bridging innate and adaptive immunity, offer significant
potential for managing inflammatory disorders like asthma. Activating iNKT induces …
potential for managing inflammatory disorders like asthma. Activating iNKT induces …
[HTML][HTML] Revolutionizing cancer treatment: the emerging potential and potential challenges of in vivo self-processed CAR cell therapy
R Lv, Y Guo, W Liu, G Dong, X Liu, C Li, Y Ren… - …, 2024 - pmc.ncbi.nlm.nih.gov
Chimeric antigen receptor (CAR) cell immunotherapies, including CAR-T, CAR-
Macrophages, CAR-Natural Killer, CAR-γδ T, etc., have demonstrated significant …
Macrophages, CAR-Natural Killer, CAR-γδ T, etc., have demonstrated significant …
Research progress on gene mutations and drug resistance in leukemia
X Ma, J Xu, Y Wang, JS Fleishman, H Bing, B Yu… - Drug Resistance …, 2024 - Elsevier
Leukemia is a type of blood cancer characterized by the uncontrolled growth of abnormal
cells in the bone marrow, which replace normal blood cells and disrupt normal blood cell …
cells in the bone marrow, which replace normal blood cells and disrupt normal blood cell …
[HTML][HTML] Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients
ME Mingot-Castellano, JL Reguera-Ortega… - Journal of Clinical …, 2024 - mdpi.com
Background/Objectives: Immune effector cell-associated hematotoxicity (ICAHT) is a
frequent adverse event after chimeric antigen receptor (CAR)-T cell therapy. Grade≥ 3 …
frequent adverse event after chimeric antigen receptor (CAR)-T cell therapy. Grade≥ 3 …
[HTML][HTML] Advancing the next generation of cancer treatment with circular RNAs in CAR-T cell therapy
Abstract Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment
of hematological malignancies. However, its effectiveness against solid tumors remains …
of hematological malignancies. However, its effectiveness against solid tumors remains …
Clinical efficacy and safety of CD7-targeted CAR T cell therapy for T-cell Malignancies: A systematic review and meta-analysis
M Dashti, MA Habibi, N Nejati… - Anti-Cancer Agents …, 2025 - benthamdirect.com
Objectives Although T-cell malignancies are relatively less prevalent compared to B-cell
malignancies, they are highly malignant, and patients usually have poor prognoses …
malignancies, they are highly malignant, and patients usually have poor prognoses …
[PDF][PDF] Exploring Immunotherapeutic Strategies For Bacterial And Viral Diseases: Recent Advances, Challenges And Future Perspectives
A Adedokun, AM Olaniyi Adigun, I Idris, P Ntasin… - 2024 - preprints.org
Antimicrobial resistance (AMR) is a growing global threat, affecting the effectiveness of
antimicrobials and posing significant challenges in the treatment of bacterial and viral …
antimicrobials and posing significant challenges in the treatment of bacterial and viral …